Safety issues related to DMARD therapy.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Rheumatology Supplement

• Publication date

  1990-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 2273518
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methotrexate-induced liver abnormalities in rheumatoid arthritis.

  1989cited by this paper
• Does aggressive therapy of rheumatoid arthritis affect outcome?

  1989cited by this paper
• TOXIC EFFECTS OF AZATHIOPRINE IN RHEUMATOID ARTHRITIS: A National Post‐Marketing Perspective

  1989cited by this paper
• Remodeling the pyramid--a concept whose time has come.

  1989cited by this paper
• Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples.

  1989cited by this paper
• Rheumatoid arthritis: can the long-term outcome be altered?

  1988cited by this paper
• A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Update after a mean of fifty-three months.

  1988cited by this paper
• Postmarketing drug surveillance: are our priorities right?

  1988cited by this paper
• Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration.

  1987cited by this paper
• Long-term outcome of treating rheumatoid arthritis: results after 20 years.

  1987cited by this paper
• Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods.

  1987cited by this paper
• Taking mortality in rheumatoid arthritis seriously--predictive markers, socioeconomic status and comorbidity.

  1986cited by this paper
• The development of disability in rheumatoid arthritis.

  1986cited by this paper
• NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND BLEEDING PEPTIC ULCER

  1986cited by this paper
• Impact of specific therapy upon rheumatoid arthritis.

  1986cited by this paper
• Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years.

  1984cited by this paper
• Does second-line therapy affect the radiological progression of rheumatoid arthritis?

  1984cited by this paper
• Does drug therapy slow radiographic deterioration in rheumatoid arthritis?

  1983cited by this paper
• Containing costs in chronic disease: monitoring strategies in the gold therapy of rheumatoid arthritis.

  1978cited by this paper

• Management strategies in rheumatoid arthritis

  2024cites this paper
• Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria

  2022cites this paper
• Prise en charge d’une polyarthrite débutante

  2017cites this paper
• A history of the term “DMARD”

  2015cites this paper
• [A short history of anti-rheumatic therapy - VI. Rheumatoid arthritis drugs].

  2011cites this paper
• Biological response modifiers in the management of rheumatoid arthritis.

  2003cites this paper
• Nuevos tratamientos para la artritis reumatoidea: drogas antirreumáticas de acción lenta disponibles y prometedoras*

  2000cites this paper
• New treatments for rheumatoid arthritis. Available and upcoming slow-acting antirheumatic drugs.

  1999cites this paper
• New therapeutic targets for rheumatoid arthritis

  1999cites this paper
• The Effectiveness of Early Treatment with Second-Line Antirheumatic Drugs

  1996cites this paper
• Advances and issues in the pharmacotherapy of rheumatoid arthritis

  1995cites this paper
• A Risk-Benefit Assessment of Slow-Acting Antirheumatic Drugs in Rheumatoid Arthritis

  1994cites this paper
• Aggressive therapy does not substantially alter the long-term course of rheumatoid arthritis. So what else is new?

  1993cites this paper
• Parvovirus B19 infection.

  1993cites this paper
• Changing perspectives in the treatment of rheumatoid arthritis.

  1992cites this paper
• Rethinking the therapeutic pyramid for rheumatoid arthritis. When are NSAIDs alone not enough?

  1992cites this paper
• Remission induction in rheumatoid arthritis.

  1992cites this paper
• Remodeling the pyramid or remodeling the paradigms concerning rheumatoid arthritis--lessons from Hodgkin's disease and coronary artery disease.

  1990cites this paper